Jim Simons
LEGN icon

Jim Simons’s Legend Biotech LEGN Stock Holding History

Jim Simons’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.44M Buy
521,800
+119,000
+30% +$2.27M 0.01% 998
2025
Q4 		$8.76M Sell
402,800
-440,400
-52% -$12.6M 0.01% 985
2025
Q3 		$27.5M Buy
843,200
+186,900
+28% +$6.9M 0.04% 586
2025
Q2 		$23.3M Sell
656,300
-54,600
-8% -$1.77M 0.03% 639
2025
Q1 		$24.1M Sell
710,900
-197,200
-22% -$7.07M 0.04% 591
2024
Q4 		$29.5M Buy
908,100
+890,000
+4,917% +$36.9M 0.04% 492
2024
Q3 		$882K Buy
+18,100
New +$964K ﹤0.01% 2521
2024
Q1 		– Sell
-122,000
Closed -$7.34M – 3911
2023
Q4 		$7.34M Buy
122,000
+21,800
+22% +$1.38M 0.01% 1101
2023
Q3 		$6.73M Buy
100,200
+86,100
+611% +$5.98M 0.01% 1136
2023
Q2 		$973K Sell
14,100
-27,200
-66% -$1.78M ﹤0.01% 2479
2023
Q1 		$1.99M Buy
41,300
+10,400
+34% +$509K ﹤0.01% 2033
2022
Q4 		$1.54M Sell
30,900
-39,300
-56% -$1.9M ﹤0.01% 2244
2022
Q3 		$2.86M Buy
+70,200
New +$3.29M ﹤0.01% 1791
2022
Q2 		– Sell
-181,100
Closed -$6.58M – 4424
2022
Q1 		$6.58M Buy
+181,100
New +$7.16M 0.01% 1402
2021
Q3 		– Sell
-60,800
Closed -$2.5M – 3671
2021
Q2 		$2.5M Buy
+60,800
New +$2.07M ﹤0.01% 2101

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.44B AUM 18.47% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jim Simons's LEGN Position: Q1 2026 in Review

Jim Simons increased its Legend Biotech (LEGN) stake by 30% in Q1 2026, buying an estimated $2.27M and bringing the position to 521,800 shares worth $9.44M. The position accounts for 0.01% of the portfolio, ranked #998.

Jim Simons first reported a position in LEGN in Q2 2021 and has held it in 15 quarters since. The position peaked at $29.5M in Q4 2024. 191 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Jim Simons held 521,800 shares of Legend Biotech worth $9.44M as of Q1 2026.
  • Jim Simons bought 119,000 Legend Biotech shares in Q1 2026, an estimated $2.27M.
  • Legend Biotech made up 0.01% of Jim Simons's portfolio in Q1 2026, its #998 holding.
  • Jim Simons first reported a position in Legend Biotech in Q2 2021 and has held it in 15 quarters since.
  • Jim Simons's Legend Biotech position peaked at $29.5M in Q4 2024.
  • 191 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.